Home/Filings/4/0001209191-23-052783
4//SEC Filing

Brady Stephen R 4

Accession 0001209191-23-052783

CIK 0001544227other

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 4:41 PM ET

Size

5.7 KB

Accession

0001209191-23-052783

Insider Transaction Report

Form 4
Period: 2023-10-11
Brady Stephen R
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-10-11+725,000725,000 total
    Exercise: $9.77Exp: 2033-10-10Common Stock (725,000 underlying)
Footnotes (1)
  • [F1]25% of the award shall vest on October 11, 2024 and the remainder of the award shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.

Issuer

Tempest Therapeutics, Inc.

CIK 0001544227

Entity typeother

Related Parties

1
  • filerCIK 0001606241

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:41 PM ET
Size
5.7 KB